Answers - Real Estate

No longer do homebuyers need to come to the table with a 20% down payment plus closing costs.

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

There are many creative solutions for borrowers who lack savings but still want to purchase

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

a home. In many instances, it is possible to purchase a home with no money out-of-pocket. T

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

wo good options are 80/20 “piggyback” loans and government-backed 100% financing.

“Piggyb

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

ck” loans

Many lenders today offer 100% financing. One of the most typical financing st

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

ructures is the “piggyback” loan. This is a two-part loan that includes both a first and sec

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

nd mortgage. The first mortgage is written for 80% of the purchase price and the second mort

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

gage makes up the remaining 20%. These loans allow for the full purchase price to be finance

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

. In addition, it avoids the necessity of private mortgage insurance since the first mortgag

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

e is only 80% of the sales price. Negotiating with the seller to pay closing costs allows th

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

homebuyer to purchase a home while bringing no money to closing.

Government-backed loans

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

In addition to piggyback loans, many lenders offer programs backed by either the state

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

r federal government that allow for 100% financing in one loan. These loans often allow the

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

buyer to finance closing costs into the loan or offer closing cost assistance. In addition,

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

any of these programs do not require private mortgage insurance which keeps the payments reas

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

onable. These loans are specifically aimed at the homebuyer with moderate income and, thus,

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

ften have income caps as part of qualification. The property may also need to be within a de

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

signated area. An experienced lender can guide you through these options to determine which

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

oan will work for your situation.

A lack of savings should not deter today’s homebuyer. Fin

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

d an experienced lender who can help you explore all of the financing options available today

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.answers.org.ua/article/142158/answers-Creative-Financing-Techniques-for-Mortgage-Loans.html">Creative Financing Techniques for Mortgage Loans</a>

BB link (for phorums):
[url=http://www.answers.org.ua/article/142158/answers-Creative-Financing-Techniques-for-Mortgage-Loans.html]Creative Financing Techniques for Mortgage Loans[/url]

Pay per click advertising is one of the most common ways of advertising being practiced by the internet marketers now days. The competition in the online world has increased a lot in the past few years. Now the websites have to...

Foreclosures are on the rise in the U.S., creating tremendous opportunities for savvy investors. In this first of a three-part series, Jordan Taylor looks at how to profit from foreclosures by preventing them.

Today's Modular homes are built better, of finer materials under controlled conditions to give the consumer the best value in affordable housing.

Tags

Links

Answers - Creative Financing Techniques for Mortgage Loans

Related Articles: